NexPoint Capital, Inc. reported a net increase in net assets of $242,570, or $0.03 per share, for the three months ended March 31, 2026, compared to a net decrease of $1,074,939, or $0.12 per share, for the same period in 2025. The company generated total income of $461,093, down from $650,016 in the prior year, while total expenses decreased to $450,043 from $502,016. The company’s net investment income was $141,749, a decline from $268,992 in the previous year, reflecting a challenging operating environment.
The company’s total net assets as of March 31, 2026, stood at $36,094,954, a decrease from $42,880,040 at the end of the previous fiscal year. The decline in net assets was attributed to shareholder distributions totaling $749,262 and a net realized loss on investments of $567,776. The company also reported a net change in unrealized appreciation of $771,673, primarily driven by the performance of its investments in NexPoint Capital REIT, LLC.
Operationally, NexPoint Capital's investment portfolio consisted of 21 interests in portfolio companies, with a total fair value of $36,753,538. The portfolio was diversified across various asset classes, including 12.4% in senior secured loans, 31.9% in common stocks, and 31.2% in preferred stocks. The company did not make any new investments during the quarter but generated significant proceeds from sales and principal repayments amounting to $1,113,330.
In terms of strategic developments, NexPoint Capital continues to focus on middle-market companies, particularly in the healthcare sector, and aims to generate high current income and long-term capital appreciation. The company has maintained its commitment to its investment strategy, which includes opportunistic investments in distressed companies and structured products. Looking ahead, the company anticipates leveraging its expertise to identify attractive investment opportunities while managing risks associated with market fluctuations and interest rate changes.
About NexPoint Capital, Inc.
NexPoint Capital, Inc. is a non-diversified, closed-end management investment company regulated as a business development company (BDC). It primarily invests in middle-market healthcare and non-healthcare companies, focusing on debt, equity, CLOs, and structured products. The firm seeks to generate current income and capital appreciation through disciplined sourcing, due diligence, and active portfolio management in the U.S. market.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.